Electronic cigarette manufacturer Juul Labs is reportedly preparing to raise funds amidst a series of consumer lawsuits and regulatory uncertainty. The US Food and Drug Administration (FDA) is attempting to force the company to withdraw from the American market. Juul is exploring its options, which may include filing for bankruptcy and awaiting further action from the FDA and the outcome of consumer lawsuits. It faces potential compensation claims amounting to hundreds of millions of dollars.
Bloomberg News reports, citing unnamed sources, that the company has hired Centerview Partners as its banker to assist with financing, and has also enlisted Kirkland & Ellis and Alvarez & Marsal to provide litigation and restructuring advice.
A spokesperson for Juul stated in an email to Axios that they are currently in the early stages of exploring various options, including potential financing choices, to protect their business as they continue to operate in the market and pursue an appeal with the FDA.
We have confidence in our science and evidence, and believe that we can demonstrate that our product does meet the legal standards for 'fit for protecting public health'.
Overall, as one of the more popular brands of electronic cigarettes, Juul's fate is closely watched as it may have an impact on the broader $23.6 billion electronic cigarette market.
What's next: It's a waiting game as the FDA conducts its review and the courts consider Juul's appeal of the ban.
In order to remain in the market, companies must demonstrate that their electronic cigarettes are beneficial to public health. In practice, this means proving that adult smokers who use electronic cigarettes may quit or reduce their smoking, while teenagers are unlikely to become addicted to electronic cigarettes.
This article is compiled from third-party information and is intended for educational and informational purposes only. The copyright of the compiled information belongs to the original media and authors. If there is any infringement, please contact us for removal.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
